Significance of incidental focal fluorine-18 fluorodeoxyglucose uptake in colon/rectum, thyroid, and prostate: With a brief literature review
Open Access
- 6 December 2022
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 10 (34) , 12532-12542
Abstract
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT), a functional imaging method, is usually per formed on the entire torso, and regions of unexpected suspicious focal hypermetabolism are not infrequently observed. Among the regions, colon, thyroid, and prostate were found to be the common organs in a recent umbrella review. Some studies reported that a high rate of malignancy was shown in incidentally identified focal hypermetabolic regions and suggested that further examinations should not be ignored. To investigate the malignancy rate of incidental focal FDG uptake, useful PET parameters and their cutoffs in discrimination between malignant and benign lesions. Retrospectively, the final reports of 16510 F-18 FDG PET/CT scans performed at our hospital between January 2016 and March 2022 were reviewed to identify incidentally observed FDG uptake in the colon/rectum, thyroid, and prostate. The scans of patients with current or prior malignancies at each corresponding location, without the final reports of histopathology or colonoscopy (for colon and rectum) for the corresponding hypermetabolic regions, or with diffuse (not focal) hypermetabolism were excluded. Finally, 88 regions of focal colorectal hyper metabolism in 85 patients (48 men and 37 women with mean age 67.0 ± 13.4 years and 63.4 ± 15.8 years, respectively), 48 focal thyroid uptakes in 48 patients (12 men and 36 women with mean age 62.2 ± 13.1 years and 60.8 ± 12.4 years, respectively), and 39 focal prostate uptakes in 39 patients (mean age 71.8 ± 7.5 years) were eligible for this study. For those unexpected focal hypermetabolic regions, rates of malignancy were calculated, PET parameters, such as standardized uptake value (SUV), capable of distinguishing between malignant and benign lesions were investigated, and the cutoffs of those PET parameters were determined by plotting receiver operating characteristic curves. In the colon and rectum, 29.5% (26/88) were malignant and 33.0% (29/88) were premalignant lesions. Both SUVmax and SUVpeak differentiated malignant/premalignant from benign lesions, however, no parameters could distinguish malignant from premalignant lesions. Higher area under the curve was shown with SUVmax (0.752, 95%CI: 0.649-0.856, P < 0.001) and the cutoff was 7.6. In the thyroid, 60.4% (29/48) were malignant. The majority were well-differentiated thyroid cancers (89.7%, 26/29). The results of BRAF mutation tests were available for 20 of the 26 well-differentiated thyroid cancers and all 20 had the mutation. Solely SUVmax differentiated malignant from benign lesions and the cutoff was 6.9. In the prostate, 56.4% (22/39) were malignant. Only SUVmax differentiated malignant from benign lesions and the cutoff was 3.8. Overall, among the 175 focal hypermetabolic regions, 60.6% (106/175) were proven to be malignant and premalignant (in colon and rectum) lesions. Approximately 60% of the incidentally observed focal F-18 FDG uptake in the colon/rectum, thyroid, and prostate were found to be malignant. Of the several PET parameters, SUVmax was superior to others in distinguishing between malignant/premalignant and benign lesions. Based on these findings, incidental focal hypermetabolism should not be ignored and lead physicians to conduct further investigations with greater confidence.Keywords
This publication has 54 references indexed in Scilit:
- The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006–2009) nationwide surveyAnnals of Nuclear Medicine, 2012
- Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography–computed tomography images?Annals of Nuclear Medicine, 2012
- Significación de captaciones incidentales en colon en estudios 18F-FDG PET-TAC en pacientes sin tumor colorrectal conocido. Valoración del impacto en el manejo del pacienteRevista Española de Medicina Nuclear e Imagen Molecular, 2012
- Management of Patients Following Detection of Unsuspected Colon Lesions by PET ImagingClinical Gastroenterology and Hepatology, 2011
- Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective studyColorectal Disease, 2011
- 18F-FDG PET/CT Imaging In OncologyAnnals of Saudi Medicine, 2011
- New Targeted Molecular Therapies for Dedifferentiated Thyroid CancerJournal of Oncology, 2010
- Incidental Finding of Focal FDG Uptake in the Bowel During PET/CT: CT Features and Correlation With Histopathologic ResultsAmerican Journal of Roentgenology, 2010
- Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomographyAnnals of Nuclear Medicine, 2009
- Clinical Significance of Diffusely Increased 18F-FDG Uptake in the Thyroid GlandJournal of Nuclear Medicine, 2007